Scientists at Israel’s Weizmann Institute have found that treating melanoma with immunotherapy is only successful if the cancer cells are homogeneous (simple / comprised of a small number of subtypes). Other treatments should be used if they are heterogeneous (complex / diverse) to achieve a more successful patient response.
Another discovery in treating melanoma
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.